DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
DiaMedica Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 8, 2019
DiaMedica Therapeutics reported fiscal year 2018 executive compensation information on April 8, 2019.
In 2018, three executives at DiaMedica Therapeutics received on average a compensation package of $600K, a 42% increase compared to previous year.
Average pay of disclosed executives at DiaMedica Therapeutics
Rick Pauls, Chief Executive Officer, received $734K in total, which increased by 46% compared to 2017. 43% of Pauls' compensation, or $315K, was in salary. Pauls also received $164K in non-equity incentive plan, $241K in option awards, as well as $13K in other compensation.
Scott Kellen, Chief Financial Officer, received a compensation package of $643K. 56% of the compensation package, or $362K, was in option awards.
Todd Verdoorn, Chief Scientific Officer, earned $423K in 2018, a 22% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 8, 2019.